QA: Cytomx Therapeutics Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001501989_2017_Cytomx_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001501989, Cytomx Therapeutics Inc

  xvar xval
0 AssetsCurrent 188,147,000
1 IntangibleAssetsNetIncludingGoodwill 949,000
2 PropertyPlantAndEquipmentNet 4,392,000
3 remainder_Assets 5,640,000
4 LiabilitiesCurrent 35,767,000
5 LiabilitiesNoncurrent 566,000
6 remainder_Liabilities 84,316,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,874,000
9 ResearchAndDevelopmentExpense 54,755,000
10 remainder_Expenses 1,670,000
11 remainder_Revenues 15,043,000
12 remainder_NetIncome 2,356,000
13 remainder_ComprehensiveNetIncome 49,000
  yvar yval
0 Assets 199,128,000
1 Liabilities 120,649,000
2 Expenses 76,299,000
3 Revenues 15,043,000
4 StockholdersEquity 78,479,000
5 NetIncome -58,900,000
6 ComprehensiveNetIncome -58,875,500
7 BaseVar 206,762,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.702
9 EconomicCapitalRatio 2.06

Edgar->Model Mapping

Feature Distribution

Change over Time